Stay updated on CD19/22 CAR T Cells in DLBCL Clinical Trial
Sign up to get notified when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.

Latest updates to the CD19/22 CAR T Cells in DLBCL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new release of the page. This likely reflects minor fixes or template updates rather than changes to the study data or narrative.SummaryDifference0.0%

- Check15 days agoChange DetectedAn additional funding/contract line was added to the study's identifiers, updating the metadata attached to the trial. This signals new funding attribution within the study record but does not alter the study design, eligibility, or reported results.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated to v3.6.5 from v3.6.4. This marks a new version of the page.SummaryDifference0.0%

- Check43 days agoChange DetectedA new site revision label 'Revision: v3.6.4' was added and the previous label 'Revision: v3.6.3' was removed, indicating a software update to the page.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded Revision: v3.6.3 to the page, indicating the latest version of the content. The prior Revision: v3.6.2 was removed, suggesting an update to the page's revision history rather than substantive changes.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision label in the page footer changed from v3.6.0 to v3.6.2, indicating a new version of the page. This is a minor update to page metadata rather than changes to the study content or results.SummaryDifference0.0%

Stay in the know with updates to CD19/22 CAR T Cells in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.